APA (7th ed.) Citation

Mukhopadhyay, P., Baggelaar, M., Erdelyi, K., Cao, Z., Cinar, R., Fezza, F., . . . van Gils, N. (2016). The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity. British Journal of Pharmacology, 173(3), 446. https://doi.org/10.1111/bph.13338

Chicago Style (17th ed.) Citation

Mukhopadhyay, Partha, et al. "The Novel, Orally Available and Peripherally Restricted Selective Cannabinoid CB2 Receptor Agonist LEI-101 Prevents Cisplatin-induced Nephrotoxicity." British Journal of Pharmacology 173, no. 3 (2016): 446. https://doi.org/10.1111/bph.13338.

MLA (9th ed.) Citation

Mukhopadhyay, Partha, et al. "The Novel, Orally Available and Peripherally Restricted Selective Cannabinoid CB2 Receptor Agonist LEI-101 Prevents Cisplatin-induced Nephrotoxicity." British Journal of Pharmacology, vol. 173, no. 3, 2016, p. 446, https://doi.org/10.1111/bph.13338.